新华制药：董事会审议通过《关于2025年度报告及业绩公告的议案》等多项议案

Core Viewpoint - Xinhua Pharmaceutical announced the approval of multiple proposals during the 10th meeting of the 11th Board of Directors, including the 2025 annual report and performance announcement, profit distribution for 2025, and the reappointment of the accounting firm [1] Group 1 - The company approved the proposal for the 2025 annual report and performance announcement [1] - The proposal regarding the profit distribution for the year 2025 was also approved [1] - The reappointment of the accounting firm was included in the approved proposals [1]